In addition to analyzing the replication mechanisms of the hepatitis B (HBV) and D (HDV) viruses, the work of Prof. Stephan Urban and his team focuses on the development of new active substances and drugs against these pathogens. With Bulevirtide (formerly Myrcludex B), which blocks the binding and entry of [...]